Literature DB >> 627133

Hemodynamic and respiratory effects of morphine and butorphanol.

K A Popio, D H Jackson, A M Ross, B F Schreiner, P N Yu.   

Abstract

The hemodynamic effects of butorphanol, a potent synthetic narcotic-antagonist analgesic, were investigated and compared with those of morphine. A total of 20 patients were studied (8 butorphanol, 12 morphine) at the time of diagnostic cardiac catheterization. Butorphanol decreased pH, PCO2, and systemic artery pressure and increased PCO2, cardiac index, and pulmonary artery pressure. Morphine caused similar changes in pH, PO2, systemic artery pressure, and PCO2 but much smaller changes in cardiac index and no change in pulmonary artery pressure. The clinical implications and possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627133     DOI: 10.1002/cpt1978233281

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

Review 1.  Adverse effects of systemic opioid analgesics.

Authors:  S A Schug; D Zech; S Grond
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

2.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Failure of opioids to affect excitation and contraction in isolated ventricular heart muscle.

Authors:  H Nawrath; J Rupp; H Jakob; U Sack; F Mertzlufft; W Dick
Journal:  Experientia       Date:  1989-04-15

4.  Pharmacological profile of PD 117302, a selective kappa-opioid agonist.

Authors:  G E Leighton; M A Johnson; K G Meecham; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

Review 5.  Adult sedation: oral, rectal, IM, IV.

Authors:  J A Giovannitti; L D Trapp
Journal:  Anesth Prog       Date:  1991 Jul-Oct

Review 6.  Agonist-antagonist opioids: theory and clinical practice.

Authors:  C Rosow
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

7.  Tolerance to the mydriatic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine in mice.

Authors:  M Kaadan; A Stav; R Rabinowitz; S Shavit; A D Korczyn
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

Review 8.  Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-12       Impact factor: 9.546

9.  Role of central and peripheral opiate receptors in the effects of fentanyl on analgesia, ventilation and arterial blood-gas chemistry in conscious rats.

Authors:  Fraser Henderson; Walter J May; Ryan B Gruber; Joseph F Discala; Veljko Puskovic; Alex P Young; Santhosh M Baby; Stephen J Lewis
Journal:  Respir Physiol Neurobiol       Date:  2013-11-24       Impact factor: 1.931

10.  The cardiovascular effects of high-dose butorphanol-nitrous oxide anaesthesia before and during operation.

Authors:  T H Stanley; P Reddy; S Gilmore; G Bennett
Journal:  Can Anaesth Soc J       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.